As per MRFR analysis, the US Venous Blood Collection Devices Market Size was estimated at 1.45 (USD Billion) in 2023. The US Venous Blood Collection Devices Market Industry is expected to grow from 1.6(USD Billion) in 2024 to 2.5 (USD Billion) by 2035. The US Venous Blood Collection Devices Market CAGR (growth rate) is expected to be around 4.141% during the forecast period (2025 - 2035).
The US Venous Blood Collection Devices Market is witnessing notable trends shaped by advancements in technology and a growing emphasis on patient safety. Increased demand for efficient and less painful blood collection methods is driving healthcare providers to adopt new devices that enhance the overall patient experience. More hospitals and laboratories are focusing on innovative materials and designs, leading to the development of devices that minimize the risk of contamination and ensure proper blood draw techniques.
Key market drivers include the rising prevalence of chronic diseases and an increased number of diagnostic tests being performed, which contributes to a heightened need for reliable venous blood collection methods. Moreover, regulatory support aimed at improving healthcare systems further stimulates the market for these devices. The US healthcare landscape is continually evolving, emphasizing quality care and safety, thereby creating opportunities for innovative blood collection solutions that align with these priorities.
Recently, there has been a noticeable shift towards the integration of digital tools in the blood collection process. The use of digital platforms and automation is improving workflow efficiency, allowing for faster turnaround times in diagnostics. This trend is reflected in the growing utilization of advanced blood collection systems that incorporate features such as RFID tracking to enhance inventory management and tracking of samples.
Additionally, with the focus on home healthcare, there is a significant opportunity to explore portable and user-friendly blood collection devices that can be used outside traditional healthcare facilities. As the US population ages and seeks convenience in healthcare, these devices can cater to the evolving needs of patients. The market continues to adapt, driven by both technological advancements and the quest for improved healthcare outcomes.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The growing prevalence of chronic diseases such as diabetes and cardiovascular diseases is significantly driving the US Venous Blood Collection Devices Market Industry. The Centers for Disease Control and Prevention (CDC) reports that approximately 34.2 million Americans, or 10.5% of the population, have diabetes, a disease that often requires routine blood tests for management.
Additionally, around 795,000 Americans suffer a stroke each year, leading to heightened blood testing needs. Such statistics suggest that the demand for venous blood collection devices is expected to increase as healthcare providers adopt more advanced diagnostic procedures. Leading organizations like the American Diabetes Association and American Heart Association emphasize the importance of regular monitoring for these chronic conditions, thereby boosting the market for blood collection devices. This growth trend aligns with the projected increase in total spending on healthcare in the United States, representing a crucial driver for the market.
Technological advancements in blood collection devices contribute profoundly to the growth of the US Venous Blood Collection Devices Market Industry. Innovations such as safety-engineered devices, which minimize the risk of needlestick injuries, have become increasingly prevalent. According to the National Institute for Occupational Safety and Health (NIOSH), needlestick injuries among healthcare workers can exceed 1,000,000 annually, fostering the need for safer blood collection systems.
Companies like BD (Becton, Dickinson and Company) are at the forefront of developing these safety-engineered devices, thereby enhancing patient safety and improving blood collection efficiency. The adoption of such advanced technology ensures that the market remains on a progressive growth curve.
The trend towards outpatient and home healthcare services in the United States is significantly impacting the US Venous Blood Collection Devices Market Industry. The US Department of Health and Human Services reports that outpatient services have increased as part of a broader effort to decongest hospitals.
This has led to a rise in the need for at-home blood collection solutions, especially among elderly patients and those with chronic conditions. Convenient blood collection options and the availability of devices that are easy to use in non-traditional settings contribute to this trend. Medtronic, one of the leading healthcare technology companies, has introduced home-use blood collection systems, catering to this growing demand and enhancing patient care, thus driving market growth.
The growing demand for diagnostic testing across various medical fields is a significant driver for the US Venous Blood Collection Devices Market Industry. The recent emphasis on early diagnosis and preventive healthcare has led to increased blood tests for various medical evaluations.
According to the American Clinical Laboratory Association, the number of laboratory tests conducted annually is expected to rise, projecting an increase of around 10% over the next decade. Companies like Quest Diagnostics are expanding their testing capabilities and accessibility, fueling the growth in demand for blood collection devices. The necessity for accurate and timely diagnostic testing is crucial as it plays a vital role in effective healthcare delivery, thereby positively impacting the market.
The US Venous Blood Collection Devices Market is primarily segmented by Type, with notable categories including Blood Collection Tubes and Lancets. Blood Collection Tubes play a critical role in the medical field as they are utilized for collecting blood specimens for various laboratory tests, making them essential for diagnostics. These tubes are designed to ensure the safe collection, transportation, and storage of blood samples, with various additives and coatings available depending on the intended laboratory analysis.
As laboratories and healthcare providers increasingly prioritize efficiency and safety in blood sampling, the demand for innovative Blood Collection Tubes has significantly increased. On the other hand, Lancets, which are small, sharp devices used to puncture the skin to obtain blood, are also vital in various medical procedures, particularly for diabetes management and point-of-care testing. Their ease of use and ability to provide quick blood samples contribute to their significance in the market.
Both segments are influenced by ongoing advancements in technology and manufacturing, which drive the development of user-friendly and safer devices. Furthermore, growing awareness regarding bloodborne diseases and the importance of safe blood collection practices are propelling the demand for high-quality Blood Collection Tubes and Lancets in the US. Regulatory requirements and healthcare compliance standards also push manufacturers toward innovation, fostering a competitive market that emphasizes quality, safety, and effectiveness.
This focus on improving patient outcomes and the shift toward more automated and efficient blood collection methods are anticipated to enhance the growth of these segments within the US Venous Blood Collection Devices Market, as stakeholders strive to meet the rising needs of a rapidly evolving healthcare industry.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The US Venous Blood Collection Devices Market is primarily segmented by Material, with significant components including Plastic, Glass, and Steel. The growing demand for venous blood collection devices in the United States has led to an increased focus on the materials used in their production. Plastic is increasingly favored due to its safety, cost-effectiveness, and flexibility in design, which facilitates manufacturing and handling.
Glass, while traditional, remains an option for its inert properties, allowing for more accurate testing results as it reduces the risk of chemical interactions. Steel is also considered for certain applications due to its durability and strength, especially in specialized devices. Each material plays a crucial role in ensuring sterilization, patient safety, and accurate diagnostics.
The growing emphasis on safety regulations and technological advancements is expected to further influence the material selection in this market. Moreover, the ongoing shifts towards disposable products to enhance infection control practices bolster the prominence of plastics. As the US healthcare system evolves, adaptability in material usage will be instrumental in meeting the challenges posed by emerging healthcare trends and sustainability objectives.
The Application segment of the US Venous Blood Collection Devices Market encompasses various critical uses, with Vein Blood Gas Sampling being one of the prominent areas. This segment plays a significant role in assessing respiratory and metabolic functions, making it crucial for timely diagnosis and treatment in clinical settings.
Due to the increasing prevalence of chronic respiratory diseases and the rising demand for accurate blood gas analysis, Vein Blood Gas Sampling has emerged as a major application in the healthcare sector. The efficiency of this sampling method allows healthcare professionals to obtain rapid results, facilitating prompt patient care. Moreover, advancements in technology are enhancing the reliability and safety of blood collection, contributing to its growing adoption in hospitals and laboratories.
With the increasing focus on patient-centered care and the emphasis on quick decision-making in medical environments, this segment is positioned to play a vital role in the US healthcare industry, which is continuously evolving to meet the needs of patients and healthcare providers alike. As the market expands, it is expected that innovations and improvements in Venous Blood Collection Devices will further enhance the significance of Vein Blood Gas Sampling, ensuring it meets future healthcare demands effectively.
The US Venous Blood Collection Devices Market is significantly influenced by its End User segment, which primarily includes Hospitals and Blood Donation Centers. Hospitals are increasingly adopting advanced blood collection devices due to a rise in outpatient procedures and the need for efficient patient care management.
These institutions often hold a majority share of the market due to their extensive patient base and continuous demand for precise diagnostic tests. On the other hand, Blood Donation Centers serve a vital role in ensuring a steady supply of blood for transfusions and medical emergencies, thereby fostering a crucial connection between donors and recipients.
The focus on safety, accuracy, and innovation in these centers directly drives the adoption of new collection technologies. Overall, the End User segment plays a fundamental role in shaping the dynamics of the US Venous Blood Collection Devices Market, reflecting broader trends in healthcare delivery and blood management practices throughout the region. Factors such as regulatory standards, the emphasis on patient safety, and the increasing prevalence of chronic diseases contribute to the ongoing evolution of this segment.
The US Venous Blood Collection Devices Market is characterized by a dynamic competitive landscape, driven by technological advancements, increasing healthcare demands, and a focus on patient safety. Manufacturers within this market are actively engaged in product development, innovation, and strategic collaborations to enhance their market presence.
The competitive insights reflect a blend of established companies and emerging players, each vying for market share by offering various blood collection products that cater to diverse medical needs. As healthcare providers demand more efficient and safer solutions for venous blood collection, the competition is expected to intensify, with players focusing on superior product features, compliance with regulatory standards, and customer service excellence.
Terumo Medical Corporation has established a significant presence in the US Venous Blood Collection Devices Market, known for its innovative products and commitment to quality. The company's strengths lie in its extensive product portfolio, which includes various blood collection systems designed to enhance efficiency and safety.
Terumo Medical Corporation's ability to leverage its advanced research and development capabilities allows it to regularly introduce new technologies that meet the evolving needs of healthcare providers. Its strong focus on customer relationships and education further solidifies its market position, making it a preferred choice among healthcare professionals in the venous blood collection segment.
Hong Kong Balsa operates within the US Venous Blood Collection Devices Market with an emphasis on providing affordable and high-quality blood collection solutions. The company's key products include various types of blood collection tubes, safety needles, and accessories, all designed to enhance the convenience and safety of blood collection procedures.
Hong Kong Balsa has built a reputation for innovation and reliability, helping it to strengthen its market presence in the US. The company’s commitment to maintaining competitive pricing while ensuring the highest safety standards is a distinct advantage. Furthermore, Hong Kong Balsa has explored strategic partnerships and mergers to expand its product offerings and enhance distribution capabilities within the US, enabling it to cater effectively to the growing demand in this sector.
The US Venous Blood Collection Devices Market has witnessed notable developments recently, particularly surrounding major companies like Terumo Medical Corporation, Abbott Laboratories, and Becton Dickinson and Company. In September 2023, Abbott Laboratories expanded its product range with innovative blood collection systems aimed at enhancing patient comfort and streamlining laboratory workflows.
Simultaneously, Terumo Medical Corporation announced advancements in their blood collection technologies, emphasizing automation and efficiency within clinical settings. In the mergers and acquisitions sector, Smiths Medical has been in discussions for a strategic partnership with Medtronic to enhance their distribution capabilities, which is expected to finalize by the end of 2023, highlighting a growing collaboration trend within the industry.
The market valuation of key players like Becton Dickinson has seen substantial growth, following increased demand fueled by the rise in diagnostic testing and outpatient procedures facilitated by regulatory support for faster approval of medical devices. The increase in market interest reflects a broader trend observed over the last two years, driven by innovations and a rising focus on enhancing patient outcomes. These developments illustrate a dynamic landscape in the US Venous Blood Collection Devices Market, characterized by technological advancements and strategic partnerships.
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 1.45(USD Billion) |
| MARKET SIZE 2024 | 1.6(USD Billion) |
| MARKET SIZE 2035 | 2.5(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 4.141% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Billion |
| KEY COMPANIES PROFILED | Terumo Medical Corporation, Hong Kong Balsa, Smiths Medical, Vacutainer, Medtronic, Abbott Laboratories, Thermo Fisher Scientific, Becton Dickinson and Company, Cardinal Health, Nipro Medical Corporation, Fisher Scientific, Gimatis, Sarstedt, Greiner BioOne, Zhenjiang Youbang Medical Instruments |
| SEGMENTS COVERED | Type, Material, Application, End User |
| KEY MARKET OPPORTUNITIES | Technological advancements in devices, Rising demand for home care, Increasing prevalence of chronic diseases, Growth in point-of-care testing, Expanding healthcare infrastructure investments |
| KEY MARKET DYNAMICS | demand for minimally invasive procedures, growing prevalence of chronic diseases, advancements in blood collection technology, increasing healthcare expenditure, emphasis on patient safety and comfort |
| COUNTRIES COVERED | US |
Frequently Asked Questions (FAQ) :
The US Venous Blood Collection Devices Market is expected to be valued at 1.6 billion USD in 2024.
By 2035, the market is projected to reach a value of 2.5 billion USD.
The anticipated CAGR for the market from 2025 to 2035 is 4.141%.
The market is segmented primarily into Blood Collection Tubes and Lancets.
The Blood Collection Tubes segment is expected to be valued at 0.96 billion USD in 2024.
The Lancets segment is projected to reach 1.0 billion USD by the year 2035.
Key players include Terumo Medical Corporation, Smiths Medical, Becton Dickinson and Company, and Abbott Laboratories.
The market is witnessing emerging trends in advanced technologies and increasing demand for safer blood collection methods.
The US market is among the largest and is expected to lead in terms of innovation and market size.
Key challenges include regulatory hurdles and competition from alternative blood collection methods.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Analyst Explore the profile of garvit vyas, one of our esteemed authors at market research future, and access their expert research contributions in the field of market research and industry analysis
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
